BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.
Pashtoon Murtaza KasiSakti ChakrabartiSarah SawyerMichael KrainockAndrew PoklepovicGeorge AnsstasMinu ManinderMeenakshi MalhotraJoe EnsorLing GaoZeynep ErogluSascha EllersPaul BillingsAngel RodriguezAlexey AleshinPublished in: BMJ open (2022)
NCT04761783.